data_6go0_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6go0 _Structure_validation_residue.Date_analyzed 2019-03-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.434 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 12' ' ' GLY . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' GLY . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 12' ' ' GLY . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.184 0.516 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 . . . . . 0 C--O 1.22 -0.478 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 121.065 0.46 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.492 0.187 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' GLY . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.563 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 17' ' ' SER . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.73 87.75 2.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 121.623 -0.673 . . . . 0.0 111.947 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp 178.87 128.78 0.07 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.699 1.2 . . . . 0.0 108.413 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -117.03 -34.19 4.48 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.923 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -130.71 119.29 22.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -72.13 174.07 7.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -51.44 -40.8 60.13 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.434 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.88 11.07 20.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 80.5 m95 . . . . . 0 C--N 1.311 -1.077 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.266 179.637 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -89.15 104.07 16.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 122.08 -0.388 . . . . 0.0 110.076 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -134.77 28.63 3.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.997 0.903 . . . . 0.0 108.606 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -102.69 -7.56 21.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.481 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -108.33 101.48 10.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.344 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -70.03 175.58 4.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.643 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -51.67 -39.23 57.84 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.13 15.29 19.43 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.288 177.476 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 120.778 0.323 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.52 -2.64 4.87 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.471 0.653 . . . . 0.0 110.261 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -121.07 159.77 25.03 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -128.99 0.16 5.27 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.75 136.76 52.85 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.697 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 t -92.17 -178.75 5.06 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -54.21 -40.71 67.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.933 0.893 . . . . 0.0 111.654 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 12' ' ' GLY . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.69 -11.08 52.28 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 83.1 m95 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 111.495 0.184 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -95.22 93.95 7.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 121.285 -0.885 . . . . 0.0 110.546 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -88.45 125.27 34.66 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.69 -44.09 24.43 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.285 0.564 . . . . 0.0 110.685 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -150.08 135.91 18.49 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 170.72 13.12 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -54.55 -44.03 72.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.433 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.617 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.71 25.18 11.55 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 . . . . . 0 C--N 1.305 -1.341 0 O-C-N 124.59 1.181 . . . . 0.0 112.488 178.802 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -111.15 -4.21 15.12 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.548 0.739 . . . . 0.0 109.981 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.75 107.29 18.19 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.085 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -100.89 -23.68 14.51 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.364 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -127.47 140.44 52.15 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.018 0.437 . . . . 0.0 109.934 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -68.85 165.65 19.36 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.281 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -52.75 -43.57 65.87 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' GLY . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.541 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.59 -5.96 8.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.4 m95 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.426 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.68 106.79 18.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.754 0.787 . . . . 0.0 112.408 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -102.55 125.16 49.18 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.97 8.33 1.62 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.75 122.35 37.85 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -71.46 172.7 9.04 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -53.4 -42.26 66.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 12' ' ' GLY . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.55 15.08 17.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 73.0 m95 . . . . . 0 C--N 1.316 -0.86 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.729 179.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -131.12 94.61 3.62 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.662 0.744 . . . . 0.0 111.23 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -126.53 136.54 52.72 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.432 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -106.6 -20.58 13.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.795 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -148.65 162.58 39.44 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.161 0.505 . . . . 0.0 109.757 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t -97.19 177.59 5.52 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.014 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -64.95 -38.33 90.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.553 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.18 -19.59 12.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 124.857 1.263 . . . . 0.0 112.265 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -2.89 17.96 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.102 -1.039 . . . . 0.0 113.237 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -80.24 144.14 33.15 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.665 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -107.0 -25.77 11.47 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.033 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.52 153.68 37.58 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.421 0.688 . . . . 0.0 109.197 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -90.6 168.33 11.88 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -55.18 -40.58 70.87 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.28 26.24 10.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.036 1.334 . . . . 0.0 113.936 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt . . . . . 0 C--O 1.244 0.786 0 CA-C-O 120.358 0.123 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.49 104.44 16.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.751 0.786 . . . . 0.0 109.874 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 93.1 mttt -75.09 -28.13 60.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.752 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 3' ' ' LYS 0.256 3.8 ptpp? 65.1 -37.69 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 128.767 2.827 . . . . 0.0 114.042 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -152.27 157.75 41.83 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -75.28 162.13 28.7 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 123.534 0.521 . . . . 0.0 110.325 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -53.1 -44.27 67.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.48 6.43 18.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 89.9 m95 . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.392 -175.328 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.5 pttt . . . . . 0 C--O 1.237 0.442 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -145.72 101.66 3.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -96.96 -78.72 0.47 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' HZ1' ' HB2' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -151.16 13.39 0.68 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -130.03 158.76 38.73 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.881 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 m -100.51 172.47 7.1 Favored 'General case' 0 C--N 1.255 -3.539 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -51.64 -42.33 61.98 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 25.2 11.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 . . . . . 0 CA--C 1.545 0.765 0 O-C-N 125.191 1.557 . . . . 0.0 113.184 -179.335 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.429 ' HZ2' ' HB3' ' A' ' 1' ' ' LYS . 9.0 mtpm? . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.59 94.65 6.95 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -75.51 -69.98 0.45 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.05 -50.12 0.06 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.168 0.508 . . . . 0.0 111.123 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -103.09 105.78 16.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 172.02 0.76 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.711 0.805 . . . . 0.0 110.579 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -49.9 -41.26 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.55 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.23 -24.76 6.33 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 C--O 1.243 0.741 0 C-N-CA 124.944 1.297 . . . . 0.0 112.305 -178.1 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.0 mptt . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 58.29 2.94 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.955 2.102 . . . . 0.0 116.573 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt 66.98 177.34 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.857 0.863 . . . . 0.0 111.313 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 21.4 pttp -160.9 -21.55 0.06 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.55 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' HG3' ' HG3' ' A' ' 4' ' ' LYS . 38.7 mt-30 -125.27 121.96 35.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.6 m -78.3 171.56 14.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.7 -40.42 28.2 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.94 10.89 34.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.7 m95 . . . . . 0 C--N 1.31 -1.152 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.696 -178.724 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -71.72 50.59 0.19 Allowed 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -123.91 140.84 52.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.32 8.36 36.46 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.044 0.45 . . . . 0.0 112.113 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -124.24 108.34 12.15 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.209 0.528 . . . . 0.0 112.043 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -80.66 177.84 8.75 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -54.36 -42.15 69.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.629 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.06 0.49 16.94 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.4 m95 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.501 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 CA--C 1.503 -0.856 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.02 -56.94 3.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 tttt 64.34 -50.36 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.465 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -45.9 -51.8 12.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.776 1.63 . . . . 0.0 115.357 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.72 110.81 23.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.564 0.697 . . . . 0.0 111.814 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -70.8 171.23 10.92 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.753 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -55.0 -39.8 69.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.468 0.707 . . . . 0.0 111.689 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.524 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.81 10.93 37.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.433 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 21.5 p-90 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.948 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt 59.68 12.35 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 127.258 2.223 . . . . 0.0 114.319 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -85.47 95.65 9.35 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.68 -31.87 11.35 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.922 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.44 127.82 22.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 t -92.48 -177.75 4.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -59.07 -39.97 83.77 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.798 0.439 . . . . 0.0 111.388 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.551 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.29 -17.53 6.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 82.1 m95 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.62 89.9 6.26 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 68.85 -179.57 0.23 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.192 1.397 . . . . 0.0 109.937 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.487 ' HG3' ' H ' ' A' ' 5' ' ' GLN . 8.7 ptpp? -123.53 -73.68 0.64 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.477 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.487 ' H ' ' HG3' ' A' ' 4' ' ' LYS . 26.6 pt20 -170.7 169.03 7.24 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -67.19 157.74 33.03 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 122.929 0.492 . . . . 0.0 110.475 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -54.04 -41.92 68.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.41 24.73 8.48 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.67 178.503 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -91.8 -16.87 26.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.354 0.597 . . . . 0.0 109.819 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 70.2 -38.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.469 1.908 . . . . 0.0 115.109 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -178.68 5.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -73.46 117.03 14.73 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 m -66.9 172.23 4.62 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.232 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -50.33 -42.55 53.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.756 0.822 . . . . 0.0 112.42 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' O ' HG22 ' A' ' 16' ' ' VAL . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 12' ' ' GLY . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.35 19.4 10.85 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.42 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 39.1 p-90 . . . . . 0 C--N 1.315 -0.925 0 O-C-N 123.842 0.713 . . . . 0.0 112.303 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -90.88 -16.46 28.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.08 0.943 . . . . 0.0 109.201 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.8 85.33 1.68 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.475 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -62.49 -50.32 71.88 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.616 1.166 . . . . 0.0 111.721 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -166.75 -179.87 5.01 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 p -91.1 155.57 18.54 Favored 'General case' 0 C--N 1.274 -2.689 0 O-C-N 123.436 0.46 . . . . 0.0 110.431 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -55.4 -38.03 68.38 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.634 0.774 . . . . 0.0 111.578 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.563 ' O ' HG21 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.423 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' OE2' ' HA ' ' A' ' 17' ' ' SER . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.77 -15.57 23.72 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--N 1.313 -1.0 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.881 -177.181 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -175.42 90.56 0.05 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 108.127 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.39 -84.59 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.638 1.175 . . . . 0.0 111.936 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB3' ' HE2' ' A' ' 4' ' ' LYS . 15.0 ptpt -159.97 -63.06 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -169.37 151.11 4.42 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.02 0.438 . . . . 0.0 111.581 -173.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -63.76 167.06 6.32 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.138 0.975 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -49.88 -44.25 49.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 113.548 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.46 24.64 7.89 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 . . . . . 0 C--N 1.309 -1.171 0 O-C-N 124.047 0.842 . . . . 0.0 111.215 178.662 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -116.06 14.67 16.07 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.296 0.57 . . . . 0.0 109.573 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.48 118.5 36.82 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -120.32 -16.69 8.4 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.754 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -136.14 137.99 41.54 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.381 1.072 . . . . 0.0 108.184 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.4 174.97 11.08 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -53.73 -40.43 66.11 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.67 -23.14 19.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 . . . . . 0 N--CA 1.431 -1.387 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.272 -176.758 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.553 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.184 0.516 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 . . . . . 0 C--O 1.22 -0.478 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 121.065 0.46 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.492 0.187 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.536 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.73 87.75 2.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 121.623 -0.673 . . . . 0.0 111.947 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp 178.87 128.78 0.07 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.699 1.2 . . . . 0.0 108.413 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -117.03 -34.19 4.48 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.923 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -130.71 119.29 22.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -72.13 174.07 7.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -51.44 -40.8 60.13 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.88 11.07 20.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 80.5 m95 . . . . . 0 C--N 1.311 -1.077 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.266 179.637 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -89.15 104.07 16.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 122.08 -0.388 . . . . 0.0 110.076 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -134.77 28.63 3.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.997 0.903 . . . . 0.0 108.606 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -102.69 -7.56 21.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.481 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -108.33 101.48 10.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.344 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -70.03 175.58 4.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.643 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -51.67 -39.23 57.84 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.13 15.29 19.43 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.288 177.476 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 120.778 0.323 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.52 -2.64 4.87 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.471 0.653 . . . . 0.0 110.261 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -121.07 159.77 25.03 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -128.99 0.16 5.27 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -126.75 136.76 52.85 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.697 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 t -92.17 -178.75 5.06 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -54.21 -40.71 67.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.933 0.893 . . . . 0.0 111.654 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.69 -11.08 52.28 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 83.1 m95 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 111.495 0.184 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -95.22 93.95 7.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 121.285 -0.885 . . . . 0.0 110.546 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -88.45 125.27 34.66 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.69 -44.09 24.43 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.285 0.564 . . . . 0.0 110.685 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -150.08 135.91 18.49 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 170.72 13.12 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -54.55 -44.03 72.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.71 25.18 11.55 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 . . . . . 0 C--N 1.305 -1.341 0 O-C-N 124.59 1.181 . . . . 0.0 112.488 178.802 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -111.15 -4.21 15.12 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.548 0.739 . . . . 0.0 109.981 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 39.4 ttmt -86.75 107.29 18.19 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.085 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -100.89 -23.68 14.51 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.364 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -127.47 140.44 52.15 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.018 0.437 . . . . 0.0 109.934 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -68.85 165.65 19.36 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.281 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -52.75 -43.57 65.87 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.553 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.59 -5.96 8.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.4 m95 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.426 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.68 106.79 18.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.754 0.787 . . . . 0.0 112.408 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -102.55 125.16 49.18 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.97 8.33 1.62 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -123.75 122.35 37.85 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -71.46 172.7 9.04 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -53.4 -42.26 66.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.55 15.08 17.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 73.0 m95 . . . . . 0 C--N 1.316 -0.86 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.729 179.825 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -131.12 94.61 3.62 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.662 0.744 . . . . 0.0 111.23 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -126.53 136.54 52.72 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.432 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -106.6 -20.58 13.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.795 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -148.65 162.58 39.44 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.161 0.505 . . . . 0.0 109.757 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t -97.19 177.59 5.52 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.014 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -64.95 -38.33 90.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.18 -19.59 12.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 124.857 1.263 . . . . 0.0 112.265 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -2.89 17.96 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.102 -1.039 . . . . 0.0 113.237 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -80.24 144.14 33.15 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.665 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -107.0 -25.77 11.47 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.033 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -149.52 153.68 37.58 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.421 0.688 . . . . 0.0 109.197 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -90.6 168.33 11.88 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -55.18 -40.58 70.87 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.28 26.24 10.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.036 1.334 . . . . 0.0 113.936 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 1' ' ' LYS . 47.5 mtmt . . . . . 0 C--O 1.244 0.786 0 CA-C-O 120.358 0.123 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.49 104.44 16.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.751 0.786 . . . . 0.0 109.874 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 93.1 mttt -75.09 -28.13 60.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.752 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 3' ' ' LYS 0.256 3.8 ptpp? 65.1 -37.69 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 128.767 2.827 . . . . 0.0 114.042 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -152.27 157.75 41.83 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -75.28 162.13 28.7 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 123.534 0.521 . . . . 0.0 110.325 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -53.1 -44.27 67.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.48 6.43 18.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 89.9 m95 . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.392 -175.328 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.5 pttt . . . . . 0 C--O 1.237 0.442 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -145.72 101.66 3.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -96.96 -78.72 0.47 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.16 13.39 0.68 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -130.03 158.76 38.73 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.881 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 m -100.51 172.47 7.1 Favored 'General case' 0 C--N 1.255 -3.539 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -51.64 -42.33 61.98 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 25.2 11.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 . . . . . 0 CA--C 1.545 0.765 0 O-C-N 125.191 1.557 . . . . 0.0 113.184 -179.335 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.59 94.65 6.95 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -75.51 -69.98 0.45 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.05 -50.12 0.06 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.168 0.508 . . . . 0.0 111.123 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -103.09 105.78 16.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 172.02 0.76 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.711 0.805 . . . . 0.0 110.579 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -49.9 -41.26 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.23 -24.76 6.33 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 C--O 1.243 0.741 0 C-N-CA 124.944 1.297 . . . . 0.0 112.305 -178.1 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.0 mptt . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 58.29 2.94 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.955 2.102 . . . . 0.0 116.573 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt 66.98 177.34 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.857 0.863 . . . . 0.0 111.313 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 21.4 pttp -160.9 -21.55 0.06 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.55 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.486 ' HG3' ' HG3' ' A' ' 4' ' ' LYS . 38.7 mt-30 -125.27 121.96 35.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.6 m -78.3 171.56 14.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.7 -40.42 28.2 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.94 10.89 34.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.7 m95 . . . . . 0 C--N 1.31 -1.152 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.696 -178.724 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -71.72 50.59 0.19 Allowed 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -123.91 140.84 52.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.32 8.36 36.46 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.044 0.45 . . . . 0.0 112.113 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -124.24 108.34 12.15 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.209 0.528 . . . . 0.0 112.043 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -80.66 177.84 8.75 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -54.36 -42.15 69.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.06 0.49 16.94 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.4 m95 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.501 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 CA--C 1.503 -0.856 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.02 -56.94 3.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 tttt 64.34 -50.36 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.465 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -45.9 -51.8 12.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.776 1.63 . . . . 0.0 115.357 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -96.72 110.81 23.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.564 0.697 . . . . 0.0 111.814 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -70.8 171.23 10.92 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.753 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -55.0 -39.8 69.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.468 0.707 . . . . 0.0 111.689 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.81 10.93 37.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.426 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 21.5 p-90 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.948 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt 59.68 12.35 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 127.258 2.223 . . . . 0.0 114.319 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -85.47 95.65 9.35 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.68 -31.87 11.35 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.922 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.44 127.82 22.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 t -92.48 -177.75 4.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -59.07 -39.97 83.77 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.798 0.439 . . . . 0.0 111.388 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.536 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.29 -17.53 6.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 82.1 m95 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.777 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.62 89.9 6.26 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 68.85 -179.57 0.23 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.192 1.397 . . . . 0.0 109.937 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HG3' ' H ' ' A' ' 5' ' ' GLN . 8.7 ptpp? -123.53 -73.68 0.64 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.477 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' H ' ' HG3' ' A' ' 4' ' ' LYS . 26.6 pt20 -170.7 169.03 7.24 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -67.19 157.74 33.03 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 122.929 0.492 . . . . 0.0 110.475 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -54.04 -41.92 68.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.41 24.73 8.48 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.67 178.503 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -91.8 -16.87 26.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.354 0.597 . . . . 0.0 109.819 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 70.2 -38.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.469 1.908 . . . . 0.0 115.109 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -178.68 5.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -73.46 117.03 14.73 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 m -66.9 172.23 4.62 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.232 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -50.33 -42.55 53.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.756 0.822 . . . . 0.0 112.42 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.35 19.4 10.85 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.413 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 39.1 p-90 . . . . . 0 C--N 1.315 -0.925 0 O-C-N 123.842 0.713 . . . . 0.0 112.303 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -90.88 -16.46 28.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.08 0.943 . . . . 0.0 109.201 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.8 85.33 1.68 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.475 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -62.49 -50.32 71.88 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.616 1.166 . . . . 0.0 111.721 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -166.75 -179.87 5.01 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 p -91.1 155.57 18.54 Favored 'General case' 0 C--N 1.274 -2.689 0 O-C-N 123.436 0.46 . . . . 0.0 110.431 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -55.4 -38.03 68.38 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.634 0.774 . . . . 0.0 111.578 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.77 -15.57 23.72 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--N 1.313 -1.0 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.881 -177.181 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -175.42 90.56 0.05 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 108.127 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 3' ' ' LYS . 0.5 OUTLIER 67.39 -84.59 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.638 1.175 . . . . 0.0 111.936 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 15.0 ptpt -159.97 -63.06 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 9' ' ' ALA . 3.7 pt20 -169.37 151.11 4.42 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.02 0.438 . . . . 0.0 111.581 -173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -63.76 167.06 6.32 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.138 0.975 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -49.88 -44.25 49.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 113.548 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.46 24.64 7.89 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 . . . . . 0 C--N 1.309 -1.171 0 O-C-N 124.047 0.842 . . . . 0.0 111.215 178.662 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -116.06 14.67 16.07 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.296 0.57 . . . . 0.0 109.573 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.48 118.5 36.82 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -120.32 -16.69 8.4 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.754 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -136.14 137.99 41.54 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.381 1.072 . . . . 0.0 108.184 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.4 174.97 11.08 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -53.73 -40.43 66.11 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.67 -23.14 19.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 . . . . . 0 N--CA 1.431 -1.387 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.272 -176.758 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 . . . . . 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.81 0.338 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.553 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 . . . . . 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 121.184 0.516 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 . . . . . 0 C--O 1.22 -0.478 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 . . . . . 0 C--O 1.234 0.255 0 CA-C-O 121.065 0.46 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.492 0.187 . . . . 0.0 111.388 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.536 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 120.969 0.414 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -129.73 87.75 2.58 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 121.623 -0.673 . . . . 0.0 111.947 -175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp 178.87 128.78 0.07 Allowed 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 124.699 1.2 . . . . 0.0 108.413 174.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -117.03 -34.19 4.48 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.923 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -130.71 119.29 22.16 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -72.13 174.07 7.65 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -51.44 -40.8 60.13 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -76.7 -30.16 56.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.335 0.588 . . . . 0.0 111.445 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.94 -46.11 54.32 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.956 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -50.32 56.51 Favored 'General case' 0 C--O 1.179 -2.62 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.29 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -35.7 70.65 Favored 'General case' 0 C--O 1.211 -0.946 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -72.34 -55.35 6.95 Favored Glycine 0 C--N 1.301 -1.368 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.136 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -64.54 -48.6 74.47 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.2 89.42 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.436 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 85.2 mt -73.9 -42.18 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.971 0.415 . . . . 0.0 111.429 -176.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.43 -43.05 97.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.564 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.469 ' HA ' ' OE1' ' A' ' 20' ' ' GLU . 4.4 t -70.78 -29.4 65.59 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.444 0.64 . . . . 0.0 110.292 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.8 -45.41 89.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.0 -37.83 95.17 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.714 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 17' ' ' SER . 43.6 mt-10 -62.09 -45.84 91.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -44.95 96.48 Favored Glycine 0 C--O 1.209 -1.417 0 CA-C-N 113.747 -1.569 . . . . 0.0 111.459 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -58.29 -34.22 70.31 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 124.191 0.996 . . . . 0.0 112.047 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 50.6 mt -70.63 -7.9 47.76 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -176.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.45 -12.76 23.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.88 11.07 20.73 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.144 0.497 . . . . 0.0 110.223 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 80.5 m95 . . . . . 0 C--N 1.311 -1.077 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.266 179.637 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.701 0.286 . . . . 0.0 111.483 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -89.15 104.07 16.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 O-C-N 122.08 -0.388 . . . . 0.0 110.076 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -134.77 28.63 3.55 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.997 0.903 . . . . 0.0 108.606 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -102.69 -7.56 21.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.481 -173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -108.33 101.48 10.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.344 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.0 m -70.03 175.58 4.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.643 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -51.67 -39.23 57.84 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -75.47 -35.59 60.83 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.317 0.579 . . . . 0.0 111.661 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.8 73.81 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.03 -47.65 70.76 Favored 'General case' 0 C--O 1.178 -2.669 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.803 178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.38 -38.63 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -72.16 -55.82 6.77 Favored Glycine 0 N--CA 1.429 -1.806 0 C-N-CA 119.129 -1.51 . . . . 0.0 111.059 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.7 -49.26 71.6 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.861 0.865 . . . . 0.0 113.092 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -63.98 -42.31 97.26 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 124.836 1.254 . . . . 0.0 111.52 -176.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.96 -40.97 52.98 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.94 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.37 -176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 12' ' ' GLY . 86.3 t -58.03 -46.95 87.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.121 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.3 t -67.6 -34.37 76.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.145 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.444 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -66.39 -44.83 81.97 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.32 -44.67 95.12 Favored Glycine 0 N--CA 1.436 -1.307 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.422 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.3 -32.7 74.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.233 0.539 . . . . 0.0 110.698 177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.12 -29.68 75.63 Favored Glycine 0 C--O 1.204 -1.762 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.698 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -80.25 -49.31 11.78 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.578 0.704 . . . . 0.0 110.749 173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 70.4 mt -62.97 -9.48 10.09 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -173.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.32 -2.86 14.79 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 123.341 0.657 . . . . 0.0 112.739 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.13 15.29 19.43 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.884 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 . . . . . 0 C--N 1.317 -0.832 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.288 177.476 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 57.5 pttt . . . . . 0 CA--C 1.51 -0.579 0 CA-C-O 120.778 0.323 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.52 -2.64 4.87 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.471 0.653 . . . . 0.0 110.261 175.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -121.07 159.77 25.03 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -128.99 0.16 5.27 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.75 136.76 52.85 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.918 -1.037 . . . . 0.0 108.697 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.4 t -92.17 -178.75 5.06 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 174.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.0 p-90 -54.21 -40.71 67.89 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 123.933 0.893 . . . . 0.0 111.654 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -76.86 -29.89 56.04 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.455 0.645 . . . . 0.0 111.338 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.21 -39.75 65.29 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.116 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -48.0 67.07 Favored 'General case' 0 C--O 1.188 -2.159 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.42 -40.04 64.81 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.922 0.764 . . . . 0.0 111.81 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.81 86.74 Favored Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.013 178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -76.6 -50.2 14.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.488 0.661 . . . . 0.0 110.17 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.53 -44.88 69.51 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 125.535 1.534 . . . . 0.0 113.101 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.4 mt -74.64 -38.85 46.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.426 0.631 . . . . 0.0 111.028 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.23 -43.4 97.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.63 0.728 . . . . 0.0 109.877 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.6 m -70.37 -24.01 62.89 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.341 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -69.75 -43.02 73.12 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -63.96 -43.56 97.27 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.798 178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -65.29 -31.12 72.09 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.847 0.832 . . . . 0.0 109.916 177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.99 -26.66 72.0 Favored Glycine 0 C--O 1.21 -1.374 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.316 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 36.9 t80 -58.53 -29.17 66.1 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 123.48 0.712 . . . . 0.0 110.936 177.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.3 mt -69.85 -7.38 39.57 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.289 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -10.72 2.43 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -86.69 -11.08 52.28 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.58 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 83.1 m95 . . . . . 0 C--N 1.312 -1.024 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 55.3 pttt . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 111.495 0.184 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -95.22 93.95 7.61 Favored 'General case' 0 N--CA 1.432 -1.342 0 O-C-N 121.285 -0.885 . . . . 0.0 110.546 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -88.45 125.27 34.66 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 174.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -78.69 -44.09 24.43 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.285 0.564 . . . . 0.0 110.685 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -150.08 135.91 18.49 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 m -71.88 170.72 13.12 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -54.55 -44.03 72.51 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.811 0.339 . . . . 0.0 111.515 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -73.55 -27.25 61.23 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.135 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -38.82 66.09 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.243 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.81 -54.43 8.87 Favored 'General case' 0 C--O 1.173 -2.922 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.01 -48.66 70.21 Favored 'General case' 0 C--O 1.211 -0.957 0 O-C-N 123.862 0.726 . . . . 0.0 111.661 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.59 -56.53 23.79 Favored Glycine 0 N--CA 1.437 -1.241 0 O-C-N 123.518 0.511 . . . . 0.0 111.952 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.77 -47.91 83.03 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-O 121.366 0.603 . . . . 0.0 111.515 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.56 -46.12 89.83 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.701 -1.136 . . . . 0.0 111.566 -177.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.2 mt -73.86 -42.96 53.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.461 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -61.22 -43.8 97.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.742 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 m -70.37 -30.62 67.59 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.605 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.449 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 0.4 OUTLIER -67.32 -46.88 72.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.63 -45.84 94.97 Favored Glycine 0 N--CA 1.439 -1.112 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.418 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -62.27 -35.89 80.38 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.593 0.711 . . . . 0.0 110.46 178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -65.84 -26.18 72.1 Favored Glycine 0 C--N 1.311 -0.823 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.666 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -81.24 -53.84 6.01 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 120.979 0.418 . . . . 0.0 111.252 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 66.0 mt -55.44 -29.99 59.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 -171.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.74 -4.27 15.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.71 25.18 11.55 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 123.419 0.687 . . . . 0.0 109.884 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 . . . . . 0 C--N 1.305 -1.341 0 O-C-N 124.59 1.181 . . . . 0.0 112.488 178.802 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -111.15 -4.21 15.12 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.548 0.739 . . . . 0.0 109.981 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 39.4 ttmt -86.75 107.29 18.19 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.085 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -100.89 -23.68 14.51 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.364 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -127.47 140.44 52.15 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 121.018 0.437 . . . . 0.0 109.934 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -68.85 165.65 19.36 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.281 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -52.75 -43.57 65.87 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -74.02 -28.93 61.67 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.384 0.611 . . . . 0.0 111.79 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.16 -41.99 63.31 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.11 -49.21 65.73 Favored 'General case' 0 C--O 1.182 -2.465 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 177.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.7 -43.74 65.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.851 0.719 . . . . 0.0 112.061 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.97 -46.71 92.19 Favored Glycine 0 C--O 1.204 -1.741 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -76.95 -49.95 14.36 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.064 0.935 . . . . 0.0 111.449 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.53 -40.45 87.23 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.913 -1.494 . . . . 0.0 113.042 -173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.5 mt -73.02 -40.56 59.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.493 0.663 . . . . 0.0 110.424 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.6 t -64.21 -41.97 94.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.985 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.2 t -69.37 -30.37 68.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.883 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -63.58 -45.47 90.27 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 177.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.553 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.28 -47.27 81.87 Favored Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.185 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -61.47 -30.34 70.54 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 123.334 0.653 . . . . 0.0 111.328 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.44 -38.19 85.75 Favored Glycine 0 C--O 1.215 -1.078 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -80.61 -51.03 9.2 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.194 0.521 . . . . 0.0 110.672 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 65.1 mt -62.87 -8.3 6.75 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.81 -172.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -23.68 67.37 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 122.073 -0.392 . . . . 0.0 111.272 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.59 -5.96 8.11 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.611 -175.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 58.4 m95 . . . . . 0 C--N 1.307 -1.273 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -177.426 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.1 tppt? -88.68 106.79 18.57 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.754 0.787 . . . . 0.0 112.408 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -102.55 125.16 49.18 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.166 -1.791 . . . . 0.0 106.166 173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -72.97 8.33 1.62 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -123.75 122.35 37.85 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.661 -174.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.5 m -71.46 172.7 9.04 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -53.4 -42.26 66.78 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -77.91 -26.08 48.84 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.296 0.569 . . . . 0.0 111.34 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.17 -40.58 64.7 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.026 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 -55.35 7.32 Favored 'General case' 0 C--O 1.174 -2.876 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.785 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.16 -39.81 69.93 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.82 -47.96 70.84 Favored Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.933 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -75.95 -49.43 17.79 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.962 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.35 -45.92 72.84 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.926 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.54 -42.71 80.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-O 121.414 0.626 . . . . 0.0 110.297 -176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.6 t -65.89 -42.58 92.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.159 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 74.0 m -71.28 -28.07 63.87 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.603 -177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -70.4 -42.57 71.51 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 121.18 0.514 . . . . 0.0 109.682 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -60.64 -52.23 53.78 Favored Glycine 0 N--CA 1.441 -0.994 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.193 176.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -63.23 -35.45 80.38 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.479 0.656 . . . . 0.0 110.753 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -31.31 80.32 Favored Glycine 0 C--O 1.202 -1.86 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.417 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -78.74 -44.21 23.92 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.279 0.562 . . . . 0.0 109.798 175.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 77.6 mt -64.06 -7.58 9.17 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -10.69 22.71 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.55 15.08 17.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 122.728 0.411 . . . . 0.0 109.988 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 73.0 m95 . . . . . 0 C--N 1.316 -0.86 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.729 179.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 CA--C 1.482 -1.667 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -131.12 94.61 3.62 Favored 'General case' 0 N--CA 1.409 -2.514 0 CA-C-O 121.662 0.744 . . . . 0.0 111.23 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -126.53 136.54 52.72 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.432 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -106.6 -20.58 13.32 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.795 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -148.65 162.58 39.44 Favored 'General case' 0 N--CA 1.419 -2.005 0 CA-C-O 121.161 0.505 . . . . 0.0 109.757 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.7 t -97.19 177.59 5.52 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.014 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -64.95 -38.33 90.61 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 123.207 0.603 . . . . 0.0 111.338 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -73.97 -13.4 60.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.714 -177.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.67 -49.26 60.46 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.26 -51.73 16.56 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.26 -43.74 64.55 Favored 'General case' 0 CA--C 1.504 -0.791 0 C-N-CA 123.513 0.725 . . . . 0.0 112.602 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.52 -54.7 34.94 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.753 178.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -69.39 -44.23 71.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.612 0.72 . . . . 0.0 111.157 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.7 -43.71 93.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 124.905 1.282 . . . . 0.0 112.37 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.67 -36.64 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.427 0.632 . . . . 0.0 110.005 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 12' ' ' GLY . 92.4 t -62.25 -43.76 98.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.325 175.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -68.95 -31.57 70.54 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.694 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -61.45 -41.45 97.23 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -66.45 -44.04 91.13 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.331 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -55.92 -36.91 68.24 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.559 0.744 . . . . 0.0 110.33 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.71 -44.34 94.13 Favored Glycine 0 C--O 1.215 -1.042 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.387 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -70.53 -36.33 73.67 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.418 0.627 . . . . 0.0 110.565 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 36.4 mt -67.75 -6.02 18.99 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -56.06 -32.96 64.55 Favored 'General case' 0 CA--C 1.555 1.153 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 173.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.18 -19.59 12.21 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.124 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.1 m95 . . . . . 0 N--CA 1.474 0.758 0 C-N-CA 124.857 1.263 . . . . 0.0 112.265 -178.51 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt . . . . . 0 C--O 1.222 -0.377 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.94 -2.89 17.96 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 119.102 -1.039 . . . . 0.0 113.237 -176.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -80.24 144.14 33.15 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.665 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -107.0 -25.77 11.47 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.033 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.52 153.68 37.58 Favored 'General case' 0 N--CA 1.435 -1.221 0 C-N-CA 123.421 0.688 . . . . 0.0 109.197 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.6 m -90.6 168.33 11.88 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.1 p-90 -55.18 -40.58 70.87 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -76.91 -25.02 52.5 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.65 -36.74 68.06 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.29 -53.79 11.42 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.3 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.18 -41.57 65.35 Favored 'General case' 0 C--O 1.219 -0.546 0 O-C-N 123.984 0.802 . . . . 0.0 111.919 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -56.35 -52.06 52.19 Favored Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.97 -48.1 39.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.468 0.652 . . . . 0.0 109.843 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.34 -44.85 68.8 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 125.385 1.474 . . . . 0.0 112.638 -175.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 82.2 mt -74.64 -40.54 47.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.837 0.351 . . . . 0.0 111.761 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.2 t -61.74 -44.96 99.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-O 121.469 0.652 . . . . 0.0 110.059 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.5 m -70.8 -23.83 62.45 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.663 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.476 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.4 t80 -71.54 -45.68 61.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.426 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.57 -45.15 93.85 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.463 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -68.41 -24.36 64.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.988 0.423 . . . . 0.0 111.156 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -64.17 -45.45 93.64 Favored Glycine 0 C--O 1.208 -1.514 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -62.21 -39.54 93.12 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.041 0.448 . . . . 0.0 110.462 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 74.2 mt -60.77 -7.94 2.66 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.86 -16.31 63.74 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.518 0.675 . . . . 0.0 109.858 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.28 26.24 10.88 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 124.657 1.183 . . . . 0.0 109.58 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.036 1.334 . . . . 0.0 113.936 -179.89 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 1' ' ' LYS . 47.5 mtmt . . . . . 0 C--O 1.244 0.786 0 CA-C-O 120.358 0.123 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -89.49 104.44 16.99 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.751 0.786 . . . . 0.0 109.874 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 93.1 mttt -75.09 -28.13 60.18 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.752 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.691 ' HG2' ' O ' ' A' ' 3' ' ' LYS 0.256 3.8 ptpp? 65.1 -37.69 0.23 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 128.767 2.827 . . . . 0.0 114.042 177.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -152.27 157.75 41.83 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.5 m -75.28 162.13 28.7 Favored 'General case' 0 C--N 1.283 -2.293 0 O-C-N 123.534 0.521 . . . . 0.0 110.325 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -53.1 -44.27 67.46 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -74.45 -20.85 59.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.922 0.391 . . . . 0.0 111.851 -177.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.24 67.11 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.36 12.28 Favored 'General case' 0 C--O 1.183 -2.414 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.73 -44.63 66.54 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.649 0.593 . . . . 0.0 111.363 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.81 -55.9 28.05 Favored Glycine 0 N--CA 1.436 -1.318 0 N-CA-C 112.021 -0.432 . . . . 0.0 112.021 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.88 -45.86 73.31 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.388 0.613 . . . . 0.0 111.115 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.38 -45.84 87.51 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 124.787 1.235 . . . . 0.0 112.518 -176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.2 mt -73.78 -38.97 51.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.169 0.509 . . . . 0.0 110.443 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 12' ' ' GLY . 98.4 t -64.81 -36.96 78.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.422 0.629 . . . . 0.0 110.136 177.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.4 t -68.72 -32.68 72.65 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.184 -0.916 . . . . 0.0 108.922 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -43.39 95.71 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 175.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -59.39 -48.9 83.7 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 175.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -63.04 -32.45 73.83 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.523 0.678 . . . . 0.0 110.894 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.56 -29.06 74.15 Favored Glycine 0 C--O 1.198 -2.108 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.356 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -78.68 -46.07 19.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 67.4 mt -65.02 -8.27 15.35 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.978 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -17.9 44.82 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.48 6.43 18.54 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.415 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 89.9 m95 . . . . . 0 N--CA 1.441 -0.903 0 CA-C-O 119.198 -0.43 . . . . 0.0 110.392 -175.328 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 51.5 pttt . . . . . 0 C--O 1.237 0.442 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -145.72 101.66 3.58 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -96.96 -78.72 0.47 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.16 13.39 0.68 Allowed 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -130.03 158.76 38.73 Favored 'General case' 0 N--CA 1.406 -2.65 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.881 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.5 m -100.51 172.47 7.1 Favored 'General case' 0 C--N 1.255 -3.539 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -51.64 -42.33 61.98 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -73.36 -33.57 65.13 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.362 0.601 . . . . 0.0 111.815 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -32.99 65.41 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.106 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.82 -55.49 6.61 Favored 'General case' 0 C--O 1.174 -2.895 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.33 69.09 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 123.989 0.806 . . . . 0.0 112.465 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.485 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.85 -55.57 29.83 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.686 -0.565 . . . . 0.0 111.686 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -63.97 -48.55 76.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.507 0.67 . . . . 0.0 111.506 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.35 -45.27 88.5 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.621 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.7 mt -72.6 -41.17 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 120.718 0.295 . . . . 0.0 111.311 -177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.1 t -59.74 -45.92 94.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.903 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -70.66 -31.42 68.33 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.378 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.8 t80 -63.82 -48.5 76.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.97 -46.97 92.97 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.374 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.02 -26.51 67.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.13 0.491 . . . . 0.0 111.201 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.86 -36.98 93.59 Favored Glycine 0 C--O 1.208 -1.483 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -80.1 -48.55 13.06 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.343 0.592 . . . . 0.0 110.194 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 60.5 mt -64.65 -7.91 12.39 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.02 -15.68 63.88 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.078 0.466 . . . . 0.0 111.522 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.5 25.2 11.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 16.0 p-90 . . . . . 0 CA--C 1.545 0.765 0 O-C-N 125.191 1.557 . . . . 0.0 113.184 -179.335 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? . . . . . 0 CA--C 1.513 -0.46 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.59 94.65 6.95 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -75.51 -69.98 0.45 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.171 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -159.05 -50.12 0.06 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.168 0.508 . . . . 0.0 111.123 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -103.09 105.78 16.17 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 172.02 0.76 Allowed 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.711 0.805 . . . . 0.0 110.579 177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -49.9 -41.26 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -176.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -75.12 -35.66 61.7 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.413 0.625 . . . . 0.0 111.84 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.79 -38.09 70.33 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.896 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.19 -49.27 61.97 Favored 'General case' 0 C--O 1.174 -2.919 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.733 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.93 -43.59 69.91 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.527 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.94 -54.96 27.18 Favored Glycine 0 N--CA 1.431 -1.666 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.501 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.57 -49.15 67.35 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.108 0.963 . . . . 0.0 112.697 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.54 -41.04 96.77 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 124.588 1.155 . . . . 0.0 112.511 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.9 mt -73.75 -37.85 49.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 120.952 0.406 . . . . 0.0 110.894 -178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.0 t -61.1 -46.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.859 175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 61.4 m -70.74 -23.72 62.48 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.905 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -64.34 -42.76 96.1 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.59 -40.59 96.1 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.138 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.1 -43.84 95.28 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.458 0.647 . . . . 0.0 109.934 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.92 99.67 Favored Glycine 0 C--N 1.306 -1.085 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.779 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -57.72 -33.39 68.38 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 111.961 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.5 mt -63.76 -6.78 6.2 Favored 'General case' 0 C--O 1.2 -1.52 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -17.78 64.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.269 0.557 . . . . 0.0 111.054 173.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.23 -24.76 6.33 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.286 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 99.1 m95 . . . . . 0 C--O 1.243 0.741 0 C-N-CA 124.944 1.297 . . . . 0.0 112.305 -178.1 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.0 mptt . . . . . 0 CA--C 1.512 -0.51 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.5 pttt 58.29 2.94 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.955 2.102 . . . . 0.0 116.573 173.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt 66.98 177.34 0.24 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.857 0.863 . . . . 0.0 111.313 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' HG3' ' HG3' ' A' ' 5' ' ' GLN . 21.4 pttp -160.9 -21.55 0.06 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.55 177.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.486 ' HG3' ' HG3' ' A' ' 4' ' ' LYS . 38.7 mt-30 -125.27 121.96 35.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.6 m -78.3 171.56 14.88 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 171.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -48.7 -40.42 28.2 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.086 0.772 . . . . 0.0 113.086 -178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -77.86 -30.49 50.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.218 0.533 . . . . 0.0 111.439 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.0 -40.09 65.49 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.98 91.74 Favored 'General case' 0 C--O 1.157 -3.78 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.823 178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.52 -37.49 57.67 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.557 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -66.53 -53.82 26.26 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -66.04 -48.37 71.3 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 124.062 0.945 . . . . 0.0 111.884 -178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -59.86 -40.52 88.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 125.653 1.581 . . . . 0.0 112.855 -176.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.2 -42.62 66.55 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.563 -179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' GLY . 48.0 t -62.75 -43.81 99.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.043 177.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.8 t -69.7 -27.37 64.95 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.941 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -65.83 -47.05 76.29 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.11 -44.13 94.6 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.739 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -64.25 -41.05 97.15 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.685 0.755 . . . . 0.0 109.907 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.55 -42.1 99.73 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.961 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -57.1 -30.84 64.69 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 124.579 1.151 . . . . 0.0 111.543 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.49 -7.17 29.72 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.504 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -9.93 33.31 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.94 10.89 34.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.173 0.511 . . . . 0.0 109.769 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 18.7 m95 . . . . . 0 C--N 1.31 -1.152 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.696 -178.724 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 CA--C 1.503 -0.839 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -71.72 50.59 0.19 Allowed 'General case' 0 CA--C 1.56 1.353 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -123.91 140.84 52.59 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -91.32 8.36 36.46 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.044 0.45 . . . . 0.0 112.113 -172.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -124.24 108.34 12.15 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.209 0.528 . . . . 0.0 112.043 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.7 m -80.66 177.84 8.75 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 67.3 p-90 -54.36 -42.15 69.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.043 0.449 . . . . 0.0 111.69 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.1 p90 -76.01 -20.68 57.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.09 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.01 -39.8 72.19 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.4 -54.23 8.8 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.737 175.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.06 -44.91 67.82 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -175.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -60.12 -51.88 56.2 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.61 -45.94 70.62 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.046 0.927 . . . . 0.0 110.697 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 -44.63 92.3 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.837 -1.528 . . . . 0.0 112.29 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.83 -36.52 46.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG23 ' O ' ' A' ' 12' ' ' GLY . 64.2 t -59.16 -47.74 89.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.815 174.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.0 m -70.23 -23.48 62.92 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.176 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -66.76 -38.24 86.2 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -68.78 -36.75 83.09 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.051 175.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -62.64 -30.24 71.22 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 121.0 0.429 . . . . 0.0 110.075 175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.96 -46.42 94.61 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.831 176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -60.5 -37.91 82.62 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.323 0.582 . . . . 0.0 110.668 176.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 76.9 mt -65.22 -7.18 11.75 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -12.53 17.06 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.06 0.49 16.94 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.562 -177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 98.4 m95 . . . . . 0 C--N 1.324 -0.521 0 CA-C-O 118.606 -0.712 . . . . 0.0 110.501 -176.621 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp . . . . . 0 CA--C 1.503 -0.856 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -86.02 -56.94 3.23 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 tttt 64.34 -50.36 0.29 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.802 2.041 . . . . 0.0 114.465 177.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -45.9 -51.8 12.55 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.776 1.63 . . . . 0.0 115.357 -172.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -96.72 110.81 23.19 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.564 0.697 . . . . 0.0 111.814 -176.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.8 t -70.8 171.23 10.92 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.753 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -55.0 -39.8 69.45 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.468 0.707 . . . . 0.0 111.689 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -78.99 -19.64 51.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.836 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.62 -38.99 77.45 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.8 -54.53 8.62 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.041 -0.981 . . . . 0.0 108.377 176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.53 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.978 0.799 . . . . 0.0 112.908 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.79 -45.53 95.6 Favored Glycine 0 C--O 1.207 -1.577 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.61 -48.99 17.4 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.735 0.778 . . . . 0.0 110.333 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -55.72 -44.51 77.54 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.534 -1.667 . . . . 0.0 112.592 -175.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 93.4 mt -73.88 -39.43 51.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.378 0.609 . . . . 0.0 110.724 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 12' ' ' GLY . 91.7 t -64.01 -42.43 95.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.323 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.5 t -69.56 -31.3 69.41 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.131 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.1 t80 -64.96 -50.73 65.27 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.22 -45.96 94.93 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.785 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.62 -27.17 65.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.314 0.578 . . . . 0.0 111.143 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -70.36 -31.43 68.62 Favored Glycine 0 C--O 1.204 -1.749 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.991 175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -78.69 -42.38 28.65 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.09 0.472 . . . . 0.0 110.373 175.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -65.64 -6.96 12.76 Favored 'General case' 0 C--O 1.21 -0.999 0 C-N-CA 124.185 0.994 . . . . 0.0 112.954 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -2.26 1.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.754 1.222 . . . . 0.0 113.248 -178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -96.81 10.93 37.47 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.218 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.426 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 21.5 p-90 . . . . . 0 C--O 1.242 0.662 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.948 177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt . . . . . 0 N--CA 1.454 -0.272 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt 59.68 12.35 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 127.258 2.223 . . . . 0.0 114.319 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -85.47 95.65 9.35 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.724 0.773 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -99.68 -31.87 11.35 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.922 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -139.44 127.82 22.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.0 t -92.48 -177.75 4.7 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.2 p-90 -59.07 -39.97 83.77 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 122.798 0.439 . . . . 0.0 111.388 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -76.22 -25.27 54.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.91 -47.93 60.55 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.14 -52.49 41.01 Favored 'General case' 0 C--O 1.182 -2.49 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.965 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.33 -34.41 64.18 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -63.53 -55.53 24.84 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -70.48 -48.41 55.89 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.003 0.43 . . . . 0.0 110.942 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.31 -44.95 68.79 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.868 1.267 . . . . 0.0 112.237 -174.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 95.5 mt -74.3 -39.36 48.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-O 120.889 0.376 . . . . 0.0 111.471 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 12' ' ' GLY . 90.8 t -61.51 -45.23 99.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-O 121.787 0.803 . . . . 0.0 109.825 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.8 m -70.15 -29.79 66.79 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.509 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.1 t80 -65.7 -45.11 84.02 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.536 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.17 -45.38 96.65 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.322 177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -63.41 -36.07 82.52 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.602 0.715 . . . . 0.0 110.835 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.33 -21.46 72.24 Favored Glycine 0 C--N 1.312 -0.759 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.6 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -81.85 -55.02 4.87 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.631 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 51.8 mt -62.21 -20.87 64.64 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.58 1.152 . . . . 0.0 113.999 -171.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.1 -16.94 63.79 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.29 -17.53 6.56 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.556 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 82.1 m95 . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -81.62 89.9 6.26 Favored 'General case' 0 N--CA 1.427 -1.581 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 177.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 68.85 -179.57 0.23 Allowed 'General case' 0 C--O 1.244 0.8 0 C-N-CA 125.192 1.397 . . . . 0.0 109.937 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.542 ' HG3' ' H ' ' A' ' 5' ' ' GLN . 8.7 ptpp? -123.53 -73.68 0.64 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.477 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.542 ' H ' ' HG3' ' A' ' 4' ' ' LYS . 26.6 pt20 -170.7 169.03 7.24 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -67.19 157.74 33.03 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 122.929 0.492 . . . . 0.0 110.475 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.8 p-90 -54.04 -41.92 68.62 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -74.63 -28.29 60.81 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-O 121.173 0.511 . . . . 0.0 111.525 -178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.83 -41.58 64.7 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.35 -51.2 64.52 Favored 'General case' 0 C--O 1.172 -3.018 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.313 176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.3 -44.53 68.39 Favored 'General case' 0 C--O 1.217 -0.614 0 O-C-N 123.744 0.653 . . . . 0.0 111.796 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -59.43 -44.01 96.99 Favored Glycine 0 C--O 1.2 -2.028 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -75.48 -49.27 19.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.013 0.911 . . . . 0.0 111.341 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -58.66 -43.44 89.83 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 125.857 1.663 . . . . 0.0 112.6 -175.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 92.1 mt -73.45 -38.68 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.223 0.535 . . . . 0.0 110.664 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 12' ' ' GLY . 99.5 t -64.24 -41.0 91.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.907 176.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.0 t -69.8 -33.91 73.01 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.606 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 1.9 t80 -63.63 -48.49 77.08 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.529 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -62.09 -46.28 94.34 Favored Glycine 0 N--CA 1.434 -1.48 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.951 178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -65.14 -29.85 70.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.425 0.631 . . . . 0.0 110.796 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.56 -31.88 81.34 Favored Glycine 0 C--O 1.216 -1.028 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.296 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -80.79 -50.78 9.41 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.273 0.559 . . . . 0.0 110.317 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 81.2 mt -61.08 -17.02 50.34 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -172.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -1.75 6.8 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 0.0 112.105 177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.41 24.73 8.48 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.301 0.64 . . . . 0.0 110.144 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 45.5 p-90 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 114.905 -1.043 . . . . 0.0 113.67 178.503 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 CA--C 1.508 -0.641 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -91.8 -16.87 26.17 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.354 0.597 . . . . 0.0 109.819 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt 70.2 -38.21 0.4 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.469 1.908 . . . . 0.0 115.109 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -178.68 5.34 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -178.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -73.46 117.03 14.73 Favored 'General case' 0 N--CA 1.408 -2.56 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.0 m -66.9 172.23 4.62 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.232 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -50.33 -42.55 53.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 123.756 0.822 . . . . 0.0 112.42 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -75.56 -21.28 58.02 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.337 0.589 . . . . 0.0 111.087 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.99 -35.71 66.92 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.08 -53.88 11.51 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.95 -42.39 65.41 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 124.057 0.848 . . . . 0.0 112.22 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.05 -48.79 65.68 Favored Glycine 0 C--O 1.206 -1.626 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -76.52 -49.31 16.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.461 0.648 . . . . 0.0 110.219 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 18' ' ' PHE . . . -53.66 -43.37 68.78 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 125.658 1.583 . . . . 0.0 112.883 -172.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 83.6 mt -74.15 -40.01 50.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.226 0.536 . . . . 0.0 110.796 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -63.58 -44.47 98.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.642 0.734 . . . . 0.0 109.826 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.1 m -70.94 -24.23 62.4 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.988 179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 14' ' ' ALA . 2.0 t80 -67.79 -43.35 79.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.48 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -61.78 -47.78 88.13 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.243 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -64.07 -35.18 79.91 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.985 0.897 . . . . 0.0 110.375 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.32 -25.61 72.49 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.561 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -81.39 -53.99 5.84 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 122.542 0.337 . . . . 0.0 111.205 170.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 43.7 mt -55.98 -32.66 64.11 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -172.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -63.39 -4.62 2.81 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.35 19.4 10.85 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 122.745 0.418 . . . . 0.0 110.688 -177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.413 ' HD1' ' O ' ' A' ' 23' ' ' LEU . 39.1 p-90 . . . . . 0 C--N 1.315 -0.925 0 O-C-N 123.842 0.713 . . . . 0.0 112.303 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 23.0 pttp . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -90.88 -16.46 28.14 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.08 0.943 . . . . 0.0 109.201 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -73.8 85.33 1.68 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.475 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -62.49 -50.32 71.88 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 124.616 1.166 . . . . 0.0 111.721 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -166.75 -179.87 5.01 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 p -91.1 155.57 18.54 Favored 'General case' 0 C--N 1.274 -2.689 0 O-C-N 123.436 0.46 . . . . 0.0 110.431 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -55.4 -38.03 68.38 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.634 0.774 . . . . 0.0 111.578 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -76.35 -20.27 57.38 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.667 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.1 82.18 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.77 -55.12 7.21 Favored 'General case' 0 C--O 1.188 -2.137 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.24 -45.54 68.78 Favored 'General case' 0 C--O 1.215 -0.754 0 O-C-N 123.954 0.784 . . . . 0.0 112.382 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.31 -55.91 26.54 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 111.775 -0.53 . . . . 0.0 111.775 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -65.65 -48.27 72.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.97 0.891 . . . . 0.0 110.63 -175.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.5 94.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.005 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.8 -37.92 49.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 122.232 -0.293 . . . . 0.0 111.468 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 12' ' ' GLY . 93.9 t -59.27 -48.02 88.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.306 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.408 ' HA ' ' OE2' ' A' ' 20' ' ' GLU . 68.9 m -71.14 -23.64 62.12 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.302 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.66 -42.4 91.39 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -65.39 -42.98 95.68 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.982 176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 44.6 mt-10 -59.58 -33.44 71.45 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.18 0.514 . . . . 0.0 110.716 177.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.95 -49.68 75.98 Favored Glycine 0 C--N 1.307 -1.069 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.796 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.97 -39.48 94.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.323 0.582 . . . . 0.0 110.955 177.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 94.6 mt -64.17 -7.21 8.31 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -11.16 1.61 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 177.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.77 -15.57 23.72 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.676 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 97.2 m95 . . . . . 0 C--N 1.313 -1.0 0 CA-C-O 118.566 -0.731 . . . . 0.0 109.881 -177.181 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -175.42 90.56 0.05 Allowed 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 108.127 174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 3' ' ' LYS . 0.5 OUTLIER 67.39 -84.59 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.638 1.175 . . . . 0.0 111.936 -178.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 4' ' ' LYS . 15.0 ptpt -159.97 -63.06 0.07 Allowed 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 176.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 10' ' ' ALA . 12.1 pt20 -169.37 151.11 4.42 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.02 0.438 . . . . 0.0 111.581 -173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.1 m -63.76 167.06 6.32 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.138 0.975 . . . . 0.0 112.475 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 66.9 p-90 -49.88 -44.25 49.81 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 113.548 -179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -71.17 -32.45 68.92 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.362 0.601 . . . . 0.0 111.336 -177.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 5' ' ' GLN . . . -73.15 -40.7 64.65 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.07 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.443 ' HA ' HE21 ' A' ' 5' ' ' GLN . . . -66.45 -51.7 54.14 Favored 'General case' 0 C--O 1.171 -3.044 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.4 -48.22 71.83 Favored 'General case' 0 C--O 1.21 -1.006 0 O-C-N 123.425 0.453 . . . . 0.0 111.183 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -61.58 -56.11 25.02 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.045 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.83 -48.32 81.11 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.816 0.846 . . . . 0.0 111.839 -177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.18 95.64 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.557 -1.201 . . . . 0.0 111.766 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 98.0 mt -73.56 -35.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.741 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 12' ' ' GLY . 54.9 t -55.88 -51.71 57.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.232 174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.5 m -70.56 -24.88 62.87 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.972 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.85 -45.49 81.96 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . -64.58 -42.74 97.26 Favored Glycine 0 N--CA 1.433 -1.508 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.456 177.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 16' ' ' VAL . 45.8 mt-10 -59.32 -37.26 77.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.316 0.579 . . . . 0.0 110.265 177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.13 -50.91 62.12 Favored Glycine 0 CA--C 1.5 -0.884 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.09 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -58.34 -38.11 76.52 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 123.419 0.688 . . . . 0.0 111.267 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 19' ' ' GLY . 87.4 mt -61.86 -8.11 4.54 Favored 'General case' 0 C--O 1.199 -1.593 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -16.69 57.91 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -99.46 24.64 7.89 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.036 0.534 . . . . 0.0 110.39 -174.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 4.7 p-90 . . . . . 0 C--N 1.309 -1.171 0 O-C-N 124.047 0.842 . . . . 0.0 111.215 178.662 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.2 pttt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -116.06 14.67 16.07 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.296 0.57 . . . . 0.0 109.573 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -106.48 118.5 36.82 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.255 -177.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -120.32 -16.69 8.4 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.754 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -136.14 137.99 41.54 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 124.381 1.072 . . . . 0.0 108.184 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.7 m -80.4 174.97 11.08 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -53.73 -40.43 66.11 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -75.72 -30.04 59.14 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.163 0.506 . . . . 0.0 111.757 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.05 -40.43 65.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.307 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.7 67.17 Favored 'General case' 0 C--O 1.184 -2.379 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.21 -42.14 66.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 123.843 0.714 . . . . 0.0 111.657 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 16' ' ' VAL . . . -57.16 -55.31 31.03 Favored Glycine 0 N--CA 1.433 -1.546 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -70.03 -49.23 53.4 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.182 0.515 . . . . 0.0 110.535 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.31 -44.66 72.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 125.024 1.33 . . . . 0.0 112.505 -174.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 89.0 mt -74.18 -40.26 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.602 0 CA-C-O 120.959 0.409 . . . . 0.0 110.621 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 12' ' ' GLY . 85.3 t -60.64 -45.7 96.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.034 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.6 m -69.77 -24.24 63.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.029 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -69.1 -44.7 71.92 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' PHE . . . -67.51 -42.37 88.92 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.495 178.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -60.58 -38.87 86.0 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.922 0.868 . . . . 0.0 109.755 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -16.06 65.92 Favored Glycine 0 C--O 1.202 -1.848 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.646 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.415 ' HB3' ' O ' ' A' ' 19' ' ' GLY . 49.7 t80 -78.63 -36.92 43.35 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.385 0.612 . . . . 0.0 110.341 176.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 72.6 mt -70.85 -8.45 52.76 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.696 -173.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.51 -8.74 49.72 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.67 -23.14 19.06 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.596 -176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 . . . . . 0 N--CA 1.431 -1.387 0 CA-C-O 118.064 -0.97 . . . . 0.0 111.272 -176.758 . . . . . . . . 0 0 . 1 stop_ save_